Tobramycin inhalation powder: an efficient and efficacious therapy for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis.
about
Antibiotic Resistance of Pseudomonas aeruginosa in Pneumonia at a Single University Hospital Center in Germany over a 10-Year Period.Adherence to tobramycin inhaled powder vs inhaled solution in patients with cystic fibrosis: analysis of US insurance claims data.Valuing Meta-Health Effects for Use in Economic Evaluations to Inform Reimbursement Decisions: A Review of the Evidence.A review of co-milling techniques for the production of high dose dry powder inhaler formulation.
P2860
Tobramycin inhalation powder: an efficient and efficacious therapy for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Tobramycin inhalation powder: ...... infection in cystic fibrosis.
@en
type
label
Tobramycin inhalation powder: ...... infection in cystic fibrosis.
@en
prefLabel
Tobramycin inhalation powder: ...... infection in cystic fibrosis.
@en
P2860
P356
P1433
P1476
Tobramycin inhalation powder: ...... infection in cystic fibrosis.
@en
P2093
Michael D Parkins
P2860
P304
P356
10.4155/TDE.14.94
P577
2015-02-01T00:00:00Z